Global RNA Vaccines Market Research Report 2019

RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.
RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of RNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.

The global RNA Vaccines market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on RNA Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall RNA Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Segment by Application
Infectious Disease
Cancer
Other

Table of Contents

Executive Summary
1 RNA Vaccines Market Overview
1.1 Product Overview and Scope of RNA Vaccines
1.2 RNA Vaccines Segment by Type
1.2.1 Global RNA Vaccines Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 RNA Vaccines Segment by Application
1.3.1 RNA Vaccines Consumption Comparison by Application (2014-2025)
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Global RNA Vaccines Market by Region
1.4.1 Global RNA Vaccines Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global RNA Vaccines Market Size
1.5.1 Global RNA Vaccines Revenue (2014-2025)
1.5.2 Global RNA Vaccines Production (2014-2025)

2 Global RNA Vaccines Market Competition by Manufacturers
2.1 Global RNA Vaccines Production Market Share by Manufacturers (2014-2019)
2.2 Global RNA Vaccines Revenue Share by Manufacturers (2014-2019)
2.3 Global RNA Vaccines Average Price by Manufacturers (2014-2019)
2.4 Manufacturers RNA Vaccines Production Sites, Area Served, Product Types
2.5 RNA Vaccines Market Competitive Situation and Trends
2.5.1 RNA Vaccines Market Concentration Rate
2.5.2 RNA Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global RNA Vaccines Production Market Share by Regions
3.1 Global RNA Vaccines Production Market Share by Regions
3.2 Global RNA Vaccines Revenue Market Share by Regions (2014-2019)
3.3 Global RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America RNA Vaccines Production
3.4.1 North America RNA Vaccines Production Growth Rate (2014-2019)
3.4.2 North America RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe RNA Vaccines Production
3.5.1 Europe RNA Vaccines Production Growth Rate (2014-2019)
3.5.2 Europe RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China RNA Vaccines Production (2014-2019)
3.6.1 China RNA Vaccines Production Growth Rate (2014-2019)
3.6.2 China RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan RNA Vaccines Production (2014-2019)
3.7.1 Japan RNA Vaccines Production Growth Rate (2014-2019)
3.7.2 Japan RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

4 Global RNA Vaccines Consumption by Regions
4.1 Global RNA Vaccines Consumption by Regions
4.2 North America RNA Vaccines Consumption (2014-2019)
4.3 Europe RNA Vaccines Consumption (2014-2019)
4.4 China RNA Vaccines Consumption (2014-2019)
4.5 Japan RNA Vaccines Consumption (2014-2019)

5 Global RNA Vaccines Production, Revenue, Price Trend by Type
5.1 Global RNA Vaccines Production Market Share by Type (2014-2019)
5.2 Global RNA Vaccines Revenue Market Share by Type (2014-2019)
5.3 Global RNA Vaccines Price by Type (2014-2019)
5.4 Global RNA Vaccines Production Growth by Type (2014-2019)

6 Global RNA Vaccines Market Analysis by Applications
6.1 Global RNA Vaccines Consumption Market Share by Application (2014-2019)
6.2 Global RNA Vaccines Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in RNA Vaccines Business
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics RNA Vaccines Production Sites and Area Served
7.1.2 RNA Vaccines Product Introduction, Application and Specification
7.1.3 Moderna Therapeutics RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 CureVac
7.2.1 CureVac RNA Vaccines Production Sites and Area Served
7.2.2 RNA Vaccines Product Introduction, Application and Specification
7.2.3 CureVac RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Translate Bio
7.3.1 Translate Bio RNA Vaccines Production Sites and Area Served
7.3.2 RNA Vaccines Product Introduction, Application and Specification
7.3.3 Translate Bio RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 BioNTech
7.4.1 BioNTech RNA Vaccines Production Sites and Area Served
7.4.2 RNA Vaccines Product Introduction, Application and Specification
7.4.3 BioNTech RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics RNA Vaccines Production Sites and Area Served
7.5.2 RNA Vaccines Product Introduction, Application and Specification
7.5.3 Sangamo Therapeutics RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics RNA Vaccines Production Sites and Area Served
7.6.2 RNA Vaccines Product Introduction, Application and Specification
7.6.3 Argos Therapeutics RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 In-Cell-Art
7.7.1 In-Cell-Art RNA Vaccines Production Sites and Area Served
7.7.2 RNA Vaccines Product Introduction, Application and Specification
7.7.3 In-Cell-Art RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 eTheRNA
7.8.1 eTheRNA RNA Vaccines Production Sites and Area Served
7.8.2 RNA Vaccines Product Introduction, Application and Specification
7.8.3 eTheRNA RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Ethris
7.9.1 Ethris RNA Vaccines Production Sites and Area Served
7.9.2 RNA Vaccines Product Introduction, Application and Specification
7.9.3 Ethris RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology RNA Vaccines Production Sites and Area Served
7.10.2 RNA Vaccines Product Introduction, Application and Specification
7.10.3 Tiba Biotechnology RNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served

8 RNA Vaccines Manufacturing Cost Analysis
8.1 RNA Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of RNA Vaccines
8.4 RNA Vaccines Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 RNA Vaccines Distributors List
9.3 RNA Vaccines Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global RNA Vaccines Market Forecast
11.1 Global RNA Vaccines Production, Revenue Forecast
11.1.1 Global RNA Vaccines Production Growth Rate Forecast (2019-2025)
11.1.2 Global RNA Vaccines Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global RNA Vaccines Price and Trend Forecast (2019-2025)
11.2 Global RNA Vaccines Production Forecast by Regions (2019-2025)
11.2.1 North America RNA Vaccines Production, Revenue Forecast (2019-2025)
11.2.2 Europe RNA Vaccines Production, Revenue Forecast (2019-2025)
11.2.3 China RNA Vaccines Production, Revenue Forecast (2019-2025)
11.2.4 Japan RNA Vaccines Production, Revenue Forecast (2019-2025)
11.3 Global RNA Vaccines Consumption Forecast by Regions (2019-2025)
11.3.1 North America RNA Vaccines Consumption Forecast (2019-2025)
11.3.2 Europe RNA Vaccines Consumption Forecast (2019-2025)
11.3.3 China RNA Vaccines Consumption Forecast (2019-2025)
11.3.4 Japan RNA Vaccines Consumption Forecast (2019-2025)
11.4 Global RNA Vaccines Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global RNA Vaccines Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures

Figure Picture of RNA Vaccines
Table Global RNA Vaccines Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global RNA Vaccines Production Market Share by Types in 2018
Figure Individualized Cancer Treatment MRNA Vaccine Product Picture
Table Individualized Cancer Treatment MRNA Vaccine Major Manufacturers
Figure Infectious Disease Treatment MRNA Vaccine Product Picture
Table Infectious Disease Treatment MRNA Vaccine Major Manufacturers
Figure Infection Prevention MRNA Vaccine Product Picture
Table Infection Prevention MRNA Vaccine Major Manufacturers
Table Global RNA Vaccines Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global RNA Vaccines Consumption Market Share by Applications in 2018
Figure Infectious Disease
Figure Cancer
Figure Other
Table RNA Vaccines Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America RNA Vaccines Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe RNA Vaccines Revenue (Million USD) and Growth Rate (2014-2025)
Figure China RNA Vaccines Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan RNA Vaccines Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global RNA Vaccines Revenue (Million USD) (2014-2025)
Figure Global RNA Vaccines Production (K Doses) (2014-2025)
Table Global RNA Vaccines Production (K Doses) of Key Manufacturers (2014-2019)
Table Global RNA Vaccines Production Share by Manufacturers (2014-2019)
Figure RNA Vaccines Production Share by Manufacturers in 2018
Table Global RNA Vaccines Revenue (Million USD) by Manufacturers (2014-2019)
Table Global RNA Vaccines Revenue Share by Manufacturers (2014-2019)
Figure Global RNA Vaccines Revenue Share by Manufacturers in 2018
Table Global Market RNA Vaccines Average Price (USD/Dose) of Key Manufacturers (2014-2019)
Figure Global Market RNA Vaccines Average Price (USD/Dose) of Key Manufacturers in 2018
Table Manufacturers RNA Vaccines Production Sites and Area Served
Table Manufacturers RNA Vaccines Product Types
Figure RNA Vaccines Market Share of Top 5 Manufacturers
Figure RNA Vaccines Market Share of Top 10 Manufacturers
Table Global RNA Vaccines Production (K Doses) by Region (2014-2019)
Table Global RNA Vaccines Production Market Share by Region (2014-2019)
Figure Global RNA Vaccines Production Market Share by Region (2014-2019)
Figure Global RNA Vaccines Production Market Share by Region in 2018
Table Global RNA Vaccines Revenue (Million USD) by Region (2014-2019)
Table Global RNA Vaccines Revenue Market Share by Region (2014-2019)
Figure Global RNA Vaccines Revenue Market Share by Region (2014-2019)
Figure Global RNA Vaccines Revenue Market Share by Region in 2018
Figure Global RNA Vaccines Production (K Doses) Growth Rate (2014-2019)
Table Global RNA Vaccines Production (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Figure North America RNA Vaccines Production (K Doses) Growth Rate (2014-2019)
Table North America RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Europe RNA Vaccines Production (K Doses) Growth Rate (2014-2019)
Table Europe RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure China RNA Vaccines Production (K Doses) Growth Rate (2014-2019)
Table China RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Japan RNA Vaccines Production (K Doses) Growth Rate (2014-2019)
Table Japan RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Global RNA Vaccines Consumption (K Doses) Market by Region (2014-2019)
Table Global RNA Vaccines Consumption Market Share by Region (2014-2019)
Figure Global RNA Vaccines Consumption Market Share by Region (2014-2019)
Figure Global RNA Vaccines Consumption Market Share by Region in 2018
Figure North America RNA Vaccines Consumption Growth Rate (2014-2019) (K Doses)
Figure Europe RNA Vaccines Consumption Growth Rate (2014-2019) (K Doses)
Figure China RNA Vaccines Consumption Growth Rate (2014-2019) (K Doses)
Figure Japan RNA Vaccines Consumption Growth Rate (2014-2019) (K Doses)
Table Global RNA Vaccines Production (K Doses) by Type (2014-2019)
Table Global RNA Vaccines Production Share by Type (2014-2019)
Figure Production Market Share of RNA Vaccines by Type (2014-2019)
Figure Production Market Share of RNA Vaccines by Type in 2018
Table Global RNA Vaccines Revenue (Million USD) by Type (2014-2019)
Table Global RNA Vaccines Revenue Share by Type (2014-2019)
Figure Revenue Share of RNA Vaccines by Type (2014-2019)
Figure Revenue Market Share of RNA Vaccines by Type in 2018
Table Global RNA Vaccines Price (USD/Dose) by Type (2014-2019)
Figure Global RNA Vaccines Production Growth by Type (2014-2019) (K Doses)
Table Global RNA Vaccines Consumption (K Doses) by Application (2014-2019)
Table Global RNA Vaccines Consumption Market Share by Application (2014-2019)
Figure Global RNA Vaccines Consumption Market Share by Applications (2014-2019)
Figure Global RNA Vaccines Consumption Market Share by Application in 2018
Table Global RNA Vaccines Consumption Growth Rate by Application (2014-2019)
Figure Global RNA Vaccines Consumption Growth Rate by Application (2014-2019)
Table Moderna Therapeutics RNA Vaccines Production Sites and Area Served
Table Moderna Therapeutics Product Introduction, Application and Specification
Table Moderna Therapeutics RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Moderna Therapeutics RNA Vaccines Production Growth Rate (2014-2019)
Figure Moderna Therapeutics RNA Vaccines Production Market Share (2014-2019)
Figure Moderna Therapeutics RNA Vaccines Revenue Market Share (2014-2019)
Table Moderna Therapeutics Main Business and Markets Served
Table CureVac RNA Vaccines Production Sites and Area Served
Table CureVac Product Introduction, Application and Specification
Table CureVac RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure CureVac RNA Vaccines Production Growth Rate (2014-2019)
Figure CureVac RNA Vaccines Production Market Share (2014-2019)
Figure CureVac RNA Vaccines Revenue Market Share (2014-2019)
Table CureVac Main Business and Markets Served
Table Translate Bio RNA Vaccines Production Sites and Area Served
Table Translate Bio Product Introduction, Application and Specification
Table Translate Bio RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Translate Bio RNA Vaccines Production Growth Rate (2014-2019)
Figure Translate Bio RNA Vaccines Production Market Share (2014-2019)
Figure Translate Bio RNA Vaccines Revenue Market Share (2014-2019)
Table Translate Bio Main Business and Markets Served
Table BioNTech RNA Vaccines Production Sites and Area Served
Table BioNTech Product Introduction, Application and Specification
Table BioNTech RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure BioNTech RNA Vaccines Production Growth Rate (2014-2019)
Figure BioNTech RNA Vaccines Production Market Share (2014-2019)
Figure BioNTech RNA Vaccines Revenue Market Share (2014-2019)
Table BioNTech Main Business and Markets Served
Table Sangamo Therapeutics RNA Vaccines Production Sites and Area Served
Table Sangamo Therapeutics Product Introduction, Application and Specification
Table Sangamo Therapeutics RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Sangamo Therapeutics RNA Vaccines Production Growth Rate (2014-2019)
Figure Sangamo Therapeutics RNA Vaccines Production Market Share (2014-2019)
Figure Sangamo Therapeutics RNA Vaccines Revenue Market Share (2014-2019)
Table Sangamo Therapeutics Main Business and Markets Served
Table Argos Therapeutics RNA Vaccines Production Sites and Area Served
Table Argos Therapeutics Product Introduction, Application and Specification
Table Argos Therapeutics RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Argos Therapeutics RNA Vaccines Production Growth Rate (2014-2019)
Figure Argos Therapeutics RNA Vaccines Production Market Share (2014-2019)
Figure Argos Therapeutics RNA Vaccines Revenue Market Share (2014-2019)
Table Argos Therapeutics Main Business and Markets Served
Table In-Cell-Art RNA Vaccines Production Sites and Area Served
Table In-Cell-Art Product Introduction, Application and Specification
Table In-Cell-Art RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure In-Cell-Art RNA Vaccines Production Growth Rate (2014-2019)
Figure In-Cell-Art RNA Vaccines Production Market Share (2014-2019)
Figure In-Cell-Art RNA Vaccines Revenue Market Share (2014-2019)
Table In-Cell-Art Main Business and Markets Served
Table eTheRNA RNA Vaccines Production Sites and Area Served
Table eTheRNA Product Introduction, Application and Specification
Table eTheRNA RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure eTheRNA RNA Vaccines Production Growth Rate (2014-2019)
Figure eTheRNA RNA Vaccines Production Market Share (2014-2019)
Figure eTheRNA RNA Vaccines Revenue Market Share (2014-2019)
Table eTheRNA Main Business and Markets Served
Table Ethris RNA Vaccines Production Sites and Area Served
Table Ethris Product Introduction, Application and Specification
Table Ethris RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Ethris RNA Vaccines Production Growth Rate (2014-2019)
Figure Ethris RNA Vaccines Production Market Share (2014-2019)
Figure Ethris RNA Vaccines Revenue Market Share (2014-2019)
Table Ethris Main Business and Markets Served
Table Tiba Biotechnology RNA Vaccines Production Sites and Area Served
Table Tiba Biotechnology Product Introduction, Application and Specification
Table Tiba Biotechnology RNA Vaccines Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Tiba Biotechnology RNA Vaccines Production Growth Rate (2014-2019)
Figure Tiba Biotechnology RNA Vaccines Production Market Share (2014-2019)
Figure Tiba Biotechnology RNA Vaccines Revenue Market Share (2014-2019)
Table Tiba Biotechnology Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA Vaccines
Figure Manufacturing Process Analysis of RNA Vaccines
Figure RNA Vaccines Industrial Chain Analysis
Table RNA Vaccines Distributors List
Table RNA Vaccines Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global RNA Vaccines Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Global RNA Vaccines Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global RNA Vaccines Price and Trend Forecast (2019-2025)
Table Global RNA Vaccines Production (K Doses) Forecast by Region (2019-2025)
Figure Global RNA Vaccines Production Market Share Forecast by Region (2019-2025)
Figure North America RNA Vaccines Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure North America RNA Vaccines Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe RNA Vaccines Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Europe RNA Vaccines Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China RNA Vaccines Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure China RNA Vaccines Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan RNA Vaccines Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Japan RNA Vaccines Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global RNA Vaccines Consumption (K Doses) Forecast by Regions (2019-2025)
Figure Global RNA Vaccines Consumption Market Share Forecast by Regions (2019-2025)
Figure North America RNA Vaccines Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure Europe RNA Vaccines Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure China RNA Vaccines Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure Japan RNA Vaccines Consumption (K Doses) Growth Rate Forecast (2019-2025)
Table Global RNA Vaccines Production (K Doses) Forecast by Type (2019-2025)
Figure Global RNA Vaccines Production (K Doses) Forecast by Type (2019-2025)
Table Global RNA Vaccines Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global RNA Vaccines Revenue Market Share Forecast by Type (2019-2025)
Table Global RNA Vaccines Price (USD/Dose) Forecast by Type (2019-2025)
Table Global RNA Vaccines Consumption (K Doses) Forecast by Application (2019-2025)
Figure Global RNA Vaccines Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type